Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia

Fig. 3

Impact on clinical outcomes by mNGS. a Changes in mortality rate (b), complete symptom resolution, and (c) duration of mechanical ventilation in control group (n = 100); mNGS group (mNGS, n = 59); those whose clinical management were changed based on mNGS results (Management Changed, n = 11); and those whose treatment was either changed (i.e. the 11 cases in the group of Management Changed) or confirmed (Management Changed/Confirmed, n = 35). d Assessment of liver and kidney function in patients with favorable clinical outcome in the mNGS group. Comparisons made between results at admission and at discharge. *, **, *** indicated P-values < 0.05, < 0.01 and < 0.001 respectively, by chi-square test and adjusted for multiple testing. ALT = alanine aminotransferase; AST = aspartate aminotransferase; ALB = albumin; BUN = blood urea nitrogen; Cr = creatinine

Back to article page